RSV-associated acute respiratory infection causes substantial morbidity, leading to
the hospitalisation of one in every 56 healthy term-born infants in high-income settings.
Immunisation of pregnant women or healthy term-born infants during their first winter
season could have a major effect on the health-care burden caused by RSV infections.